期刊文献+

流产布鲁氏菌疫苗候选株RB6生物学特性研究 被引量:5

Study on the Biological Characteristics of Vaccine Candidate RB6 Derived from Brucella abortus
下载PDF
导出
摘要 为了开发布鲁氏菌病新型标记疫苗,本研究对流产布鲁氏菌基因缺失株RB6的培养特性、染色特性、凝集特性、稳定性及小鼠体内毒力和免疫保护力进行了系统鉴定,旨在阐明该菌株具备的生物学特性。通过对亲本菌株和RB6的比较,发现固体培养基上RB6菌株单菌落可被结晶紫染成紫色,RB6菌株液体培养物可与0.1%吖啶黄染料以及抗布鲁氏菌粗糙型抗体发生凝集反应,证明该菌株为粗糙型。将RB6菌株在体外连续传代培养20次和牛体内连续5次继代,检测结果证明其表型未发生变化,说明该菌株遗传稳定性良好。通过小鼠体内试验发现该菌株毒力显著降低,并对流产布鲁氏菌强毒菌株2308攻毒的免疫保护力与现有疫苗A19接近。本研究结果表明,流产布鲁氏菌基因缺失株RB6为粗糙型菌株,毒力较低、安全性高、遗传性状稳定,并具有良好的免疫保护效力,有望开发成为动物布鲁氏菌病粗糙型标记疫苗。 To develop a novel marker brucellosis vaccine,the gene-deleted mutant RB6 derived from Brucella abortus was used in this paper to examine its essential properties.By comparing growth characteristics,staining properties,agglutination identities,stability,virulence and immunological protection between RB6 and its parent strain,it was found that the growth characteristics of RB6 was similar to the parent strain,but the colonies on TSA became to the violet in the crystal violet staining test,and the cultural suspension was agglutinated with sera against Brucella rough-type strain,which showed that RB6 was a rough phenotype.It was also demonstrated that the phenotype and virulence of RB6 was stable when it was subcultured for 20 passages in vitro and then for 5 passages in heifers.In the mice model,RB6 was attenuated and induced the similar immunological protection levels as A19 vaccine strain.In a word,RB6 was a rough-type mutant with low virulence,high genetic stability and good protection efficacy,which could be employed to prepare new marker vaccines using for the prevention and control of animal brucellosis.
出处 《中国畜牧兽医》 CAS 北大核心 2012年第4期174-177,共4页 China Animal Husbandry & Veterinary Medicine
基金 国家973计划(2010CB530202)
关键词 流产布鲁氏菌 粗糙型疫苗 稳定性 毒力 免疫效力 Brucella abortus rough-type vaccine stability virulence immune efficacy
  • 相关文献

参考文献8

  • 1赵茜;吴清民;任婕.流产布鲁氏菌转座子突变株文库构建及毒力基因的初步鉴定[A],2008.
  • 2唐婕,杨艳玲,王兴龙,郎需龙,李晓艳.牛布鲁氏菌膜蛋白的免疫抗原筛选[J].中国畜牧兽医,2010,37(7):136-139. 被引量:4
  • 3Alcina V,Carvalho N. Pathogenesis of bovine brucellosis[J].Veterinary Journal,2010,(02):146-155.
  • 4Alton G G,Pietz D E. Laboratory techniques in brucellosis[M].Geneva:World Health Organization,1975.
  • 5David G,Maria-Jesus G. Brucellosis vaccine:assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export[J].PLoS ONE,2008,(07):e2760.doi:10.1371/journal.pone.0002760.
  • 6Ignacio M,Maria-Jesus G. Rough vaccines in animal brucellosis:structural and genetic basis and present status[J].Veterinary Research,2004.1-38.
  • 7Juan E U,Comerci D J. Evaluation of Brucella abortus phosphoglucomutase(pgm) mutant as a new live rough-phenotype vaccine[J].Inf and Imm,2003.6264-6269.
  • 8Tumurkhuu G,Koide N,Takahashi K. Characterization of biological activities of Brucella melitensis lipopolysaccharide[J].Microbiology and Immunology,2006.421-427.

二级参考文献10

  • 1曾政.布鲁氏菌毒力、免疫相关分子的筛选研究[D].北京:中国人民解放军军事医学科学院,2008.
  • 2Axel C,Nieves V,Jean Y P,et al.Major outer membrane proteins of Brucella spp:past,present and future[J].Veterinary Microbiology,2002,90:229-247.
  • 3Connolly J P,Comerci D,Alefantis T G,et al.Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development[J].Proteomics,2006,6:3767-3780.
  • 4Contreras-Rodriguez A,Ramirez-Zavala B,Contreras A,et al.Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis[J].Infection and Immunity,2003,71:5238-5244.
  • 5Henningsen R,Gale B L,Straub K M,et al.Application of zwitterionic detergents to the solubilization of integral membrane proteins for two-dimensional gel electrophoresis and mass spectrometry[J].Proteomics,2002,2(11):1479-1488.
  • 6Isabelle J,Jean M V,Karine L,et al.Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B.melitensis Rev.1 deletion mutants in sheep[J].Vaccine,2007(25):794-805.
  • 7Jinkyung Ko,et al.Molecular host-pathogen interaction in brucellosis:Current understanding and future approaches to vaccine development for mice and humans[J].Clinical Microbiology Review,2003,16:65-78.
  • 8Joseph P C,Diego C,Timothy G A,et al.Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development[J].Proteomics,2006(6):3767-3780.
  • 9Paola C H,Luis F L,et al.Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis[J].Infection and Immunity,2007,75:4050-4061.
  • 10Sascha A D,Karsten N,Holger C S,et al.Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections[J].Journal of Immunological Methods,2006,309:34-47.

共引文献3

同被引文献30

引证文献5

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部